// App-Quantinova.ai

P647 : Tuberculosis in patients treated with vedolizumab: clinical trial and post-marketing case series

Researchers

Presenter

  • M. Zerncio

Principal Investigators

  • A. Blake

  • Q. Rana-Khan

  • W. Palo

  • F. Bhayat

Medical Centers

  • Clínica de Oncologia de Natal, Gastroenterology, Natal, Brazil

  • Takeda Development Center Europe Ltd, Global Pharmacovigilance, London, United Kingdom

  • Takeda Pharmaceutical International AG Singapore, Emerging Markets Medical Affairs, Singapore, Singapore

  • Takeda Development Center Americas, Inc., Global Statistics and Statistical Programming, Deerfield, United States

  • Takeda Development Center Europe Ltd, Global Pharmacovigilance, London, United Kingdom

Locations

  • Brazil

  • United Kingdom

  • Singapore

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • Placebo Control

  • Open Label

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved